Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 28 04:00PM ET
33.25
Dollar change
+0.32
Percentage change
0.97
%
IndexRUT P/E15.78 EPS (ttm)2.11 Insider Own21.90% Shs Outstand128.37M Perf Week-1.66%
Market Cap4.32B Forward P/E14.97 EPS next Y2.22 Insider Trans-1.21% Shs Float101.56M Perf Month21.31%
Income259.97M PEG0.50 EPS next Q0.62 Inst Own76.68% Short Float2.09% Perf Quarter19.09%
Sales6.79B P/S0.64 EPS this Y5.18% Inst Trans-3.27% Short Ratio3.89 Perf Half Y40.89%
Book/sh10.65 P/B3.12 EPS next Y6.10% ROA3.34% Short Interest2.12M Perf Year22.47%
Cash/sh0.71 P/C46.68 EPS next 5Y31.82% ROE20.49% 52W Range21.28 - 35.08 Perf YTD41.49%
Dividend Est.0.25 (0.75%) P/FCF17.93 EPS past 5Y13.25% ROI4.23% 52W High-5.22% Beta1.43
Dividend TTM0.50 (1.50%) Quick Ratio1.22 Sales past 5Y5.64% Gross Margin11.34% 52W Low56.25% ATR (14)0.77
Dividend Ex-DateMay 15, 2024 Current Ratio1.22 EPS Y/Y TTM49.84% Oper. Margin8.74% RSI (14)60.64 Volatility2.16% 2.71%
Employees54600 Debt/Eq3.74 Sales Y/Y TTM6.08% Profit Margin3.83% Recom1.50 Target Price39.00
Option/ShortYes / Yes LT Debt/Eq3.49 EPS Q/Q35.58% Payout26.22% Rel Volume0.67 Prev Close32.93
Sales Surprise2.90% EPS Surprise35.66% Sales Q/Q7.44% EarningsMay 02 AMC Avg Volume545.28K Price33.25
SMA202.68% SMA5010.62% SMA20024.75% Trades Volume366,897 Change0.97%
Date Action Analyst Rating Change Price Target Change
May-13-21Reiterated The Benchmark Company Buy $40 → $44
Feb-26-21Upgrade BofA Securities Underperform → Buy $30 → $36
Jun-16-20Downgrade BofA/Merrill Neutral → Underperform $18 → $15
Sep-17-19Initiated Deutsche Bank Buy $22
May-17-19Upgrade JMP Securities Mkt Perform → Mkt Outperform $18
Dec-14-18Initiated Barclays Equal Weight
Oct-16-18Initiated Credit Suisse Neutral $18
Feb-27-18Upgrade JMP Securities Mkt Underperform → Mkt Perform
Jan-30-18Resumed Wells Fargo Outperform
Jan-04-18Upgrade BofA/Merrill Underperform → Neutral
May-24-24 09:40AM
May-21-24 09:50AM
May-07-24 02:15PM
09:40AM
09:40AM
09:39AM Loading…
May-06-24 09:39AM
08:03AM
May-04-24 09:50AM
03:06AM
May-03-24 10:32PM
May-02-24 10:53PM
06:12PM
04:53PM
04:30PM
Apr-05-24 08:00AM
10:38AM Loading…
Apr-03-24 10:38AM
Mar-19-24 12:09PM
Mar-18-24 09:44AM
08:00AM
Feb-27-24 06:16PM
08:24AM
Feb-23-24 11:03PM
12:22PM
Feb-22-24 05:55PM
05:12PM
04:58PM
04:30PM
Feb-20-24 11:42AM
Feb-15-24 10:00AM
Jan-22-24 04:30PM
10:20AM Loading…
Jan-06-24 10:20AM
Jan-05-24 09:49AM
Jan-04-24 11:55AM
09:50AM
Jan-03-24 04:15PM
Jan-01-24 09:40AM
Dec-07-23 09:40AM
Dec-06-23 10:57PM
Dec-01-23 08:59AM
Nov-07-23 12:26PM
Nov-05-23 01:45PM
Nov-03-23 10:18PM
09:08AM
08:08AM
Nov-02-23 06:53PM
06:44PM
04:30PM
11:05AM
Oct-26-23 10:02AM
Oct-25-23 09:40AM
Oct-19-23 12:00PM
04:29AM
Oct-18-23 09:40AM
Oct-17-23 08:35AM
06:03AM
Oct-16-23 08:45AM
Oct-13-23 06:27AM
Oct-10-23 06:23AM
Oct-04-23 08:00AM
Oct-02-23 09:40AM
Sep-29-23 08:24AM
07:39AM
Sep-28-23 07:26AM
Sep-19-23 04:51AM
Sep-18-23 12:20PM
Sep-14-23 08:38AM
04:46AM
Sep-13-23 10:06AM
Sep-12-23 01:01AM
Sep-07-23 04:30PM
Aug-31-23 01:44PM
Aug-29-23 08:50AM
Aug-25-23 09:40AM
Aug-24-23 10:05AM
Aug-09-23 06:09AM
Aug-07-23 06:03AM
Aug-05-23 12:13AM
Aug-04-23 12:08PM
Aug-03-23 06:44PM
04:30PM
Jul-30-23 08:40AM
Jul-21-23 11:52AM
Jul-19-23 04:15PM
Jul-14-23 11:59AM
Jul-07-23 08:00AM
Jul-05-23 09:24AM
Jun-21-23 08:00PM
Jun-16-23 10:14AM
Jun-06-23 09:54AM
May-12-23 06:12AM
May-08-23 06:02AM
May-06-23 12:41AM
May-05-23 10:49AM
May-04-23 07:35PM
06:32PM
04:30PM
Apr-29-23 09:16AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
Apr-11-23 06:22AM
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran's healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ORTENZIO ROBERT AEXECUTIVE CHAIRMANApr 08 '24Sale29.9050,0001,495,0006,689,668Apr 10 04:44 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANMar 08 '24Sale28.3050,0001,415,0006,739,668Mar 11 04:43 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANFeb 08 '24Sale26.0050,0001,300,0006,789,668Feb 09 04:34 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJan 08 '24Sale26.63100,0002,663,0006,839,668Jan 09 04:42 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANDec 14 '23Sale25.00100,0002,500,0006,939,668Dec 14 04:57 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANSep 08 '23Sale26.8250,0001,341,0007,039,668Sep 11 04:01 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANAug 08 '23Sale29.5250,0001,476,0007,089,668Aug 09 05:40 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJul 10 '23Sale30.3650,0001,518,0006,889,668Jul 11 06:43 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJun 29 '23Sale32.00100,0003,200,0001,279,000Jun 30 05:27 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJun 21 '23Sale30.0033,9671,019,0101,379,000Jun 22 06:00 PM
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJun 08 '23Sale28.6350,0001,431,5006,939,668Jun 09 05:13 PM
Last Close
May 28 04:00PM ET
7.31
Dollar change
-0.15
Percentage change
-2.01
%
IndexRUT P/E- EPS (ttm)-0.86 Insider Own1.13% Shs Outstand84.02M Perf Week-2.01%
Market Cap615.14M Forward P/E5.76 EPS next Y1.27 Insider Trans-0.82% Shs Float83.20M Perf Month-19.14%
Income-70.58M PEG- EPS next Q0.32 Inst Own102.13% Short Float5.30% Perf Quarter-18.87%
Sales2.00B P/S0.31 EPS this Y-3.00% Inst Trans-2.22% Short Ratio5.70 Perf Half Y-17.31%
Book/sh10.19 P/B0.72 EPS next Y3.85% ROA-3.15% Short Interest4.41M Perf Year-44.91%
Cash/sh1.37 P/C5.33 EPS next 5Y-4.58% ROE-7.99% 52W Range7.26 - 15.02 Perf YTD-21.40%
Dividend Est.- P/FCF7.56 EPS past 5Y- ROI-4.42% 52W High-51.33% Beta1.54
Dividend TTM- Quick Ratio1.72 Sales past 5Y-7.30% Gross Margin19.06% 52W Low0.72% ATR (14)0.36
Dividend Ex-Date- Current Ratio1.72 EPS Y/Y TTM-169.64% Oper. Margin7.61% RSI (14)29.23 Volatility4.09% 4.64%
Employees8070 Debt/Eq0.91 Sales Y/Y TTM0.91% Profit Margin-3.53% Recom3.11 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq0.87 EPS Q/Q-71.96% Payout- Rel Volume1.21 Prev Close7.46
Sales Surprise-0.57% EPS Surprise8.70% Sales Q/Q0.83% EarningsMay 07 BMO Avg Volume773.68K Price7.31
SMA20-12.30% SMA50-18.24% SMA200-28.91% Trades Volume936,491 Change-2.01%
Date Action Analyst Rating Change Price Target Change
Sep-27-21Initiated SVB Leerink Mkt Perform $29
Jun-23-21Resumed Stifel Hold $30
Oct-19-20Downgrade Deutsche Bank Hold → Sell $20 → $12
Jan-03-20Downgrade Citigroup Buy → Neutral $29
Dec-12-19Upgrade Stifel Hold → Buy $25 → $33
Sep-06-19Downgrade BofA/Merrill Neutral → Underperform
Jan-15-19Upgrade Citigroup Neutral → Buy
Jan-03-19Initiated Deutsche Bank Hold $34
Nov-16-18Initiated UBS Sell $37
Sep-24-18Upgrade Leerink Partners Mkt Perform → Outperform
May-22-24 06:45AM
May-08-24 11:26AM
May-07-24 10:54AM
09:30AM
06:00AM
06:45AM Loading…
Apr-22-24 06:45AM
Mar-21-24 11:30AM
Feb-21-24 08:20AM
Feb-20-24 09:30AM
06:00AM
Feb-15-24 12:13PM
Feb-13-24 06:45AM
Feb-07-24 06:45AM
Nov-16-23 02:20PM
Nov-06-23 09:19AM
06:00AM Loading…
Nov-02-23 06:00AM
Oct-26-23 10:02AM
Oct-20-23 06:45AM
Aug-29-23 12:07PM
Aug-03-23 06:00AM
Jul-18-23 06:45AM
Jun-21-23 08:00PM
Jun-10-23 09:10AM
May-24-23 09:34AM
May-04-23 04:05PM
May-03-23 06:45AM
May-02-23 06:00AM
Apr-27-23 10:03AM
Apr-26-23 08:00PM
10:18AM
06:45AM Loading…
06:45AM
Mar-20-23 10:39AM
Mar-08-23 05:36PM
Feb-21-23 06:45AM
Feb-17-23 06:00AM
Feb-10-23 10:00AM
Feb-06-23 06:45AM
Feb-04-23 07:52AM
Jan-01-23 07:31AM
Dec-15-22 07:23PM
04:41PM
07:25AM
Dec-01-22 06:50AM
Nov-17-22 09:08AM
Nov-07-22 06:45AM
Nov-03-22 06:00AM
Oct-21-22 06:45AM
Oct-13-22 09:40AM
Oct-11-22 07:36AM
Aug-22-22 03:00PM
Aug-04-22 07:35AM
06:00AM
Jul-28-22 10:03AM
Jul-27-22 06:05PM
Jul-24-22 10:08AM
Jul-13-22 06:45AM
Jul-08-22 07:48AM
Jul-05-22 01:55PM
Jun-22-22 09:39AM
Jun-21-22 06:45AM
Jun-08-22 06:45AM
Jun-07-22 10:49AM
May-18-22 06:45AM
May-10-22 11:35AM
May-04-22 06:40AM
Apr-28-22 07:15AM
06:00AM
Apr-25-22 05:25PM
Apr-22-22 09:51AM
08:55AM
Apr-19-22 06:45AM
Apr-05-22 07:30AM
Mar-31-22 02:35PM
11:05AM
Mar-28-22 11:07AM
Mar-24-22 01:35PM
Mar-22-22 07:30AM
Mar-21-22 01:53PM
Mar-16-22 01:24PM
11:54AM
Mar-11-22 01:54PM
Mar-10-22 09:35AM
Mar-07-22 08:03AM
Mar-03-22 10:46AM
Mar-02-22 05:36PM
07:00AM
Mar-01-22 10:09AM
Feb-25-22 08:45AM
Feb-24-22 07:00AM
Feb-23-22 07:00AM
Feb-18-22 01:57PM
Feb-17-22 03:08PM
08:21AM
07:15AM
06:45AM
06:00AM
Feb-16-22 06:35PM
09:48AM
Feb-15-22 09:27AM
Feb-14-22 12:34PM
Pediatrix Medical Group, Inc. engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swift James DChief Executive OfficerDec 14 '23Sale9.585,76455,21990,874Dec 15 05:00 PM
Moore Mary Ann EEVP, General Counsel & SecDec 14 '23Sale9.621,15011,06315,730Dec 15 05:00 PM
Moore Mary Ann EEVP, General Counsel & SecDec 14 '23Sale9.629709,33181,385Dec 15 05:00 PM
Swift James DChief Executive OfficerJun 14 '23Sale14.1413,193186,54996,638Jun 16 05:00 PM
Last Close
May 28 04:00PM ET
83.47
Dollar change
-1.02
Percentage change
-1.21
%
Index- P/E22.50 EPS (ttm)3.71 Insider Own1.54% Shs Outstand100.25M Perf Week-3.07%
Market Cap8.40B Forward P/E18.13 EPS next Y4.60 Insider Trans-4.17% Shs Float99.13M Perf Month1.21%
Income375.40M PEG1.53 EPS next Q1.01 Inst Own98.09% Short Float1.67% Perf Quarter10.79%
Sales4.96B P/S1.70 EPS this Y12.82% Inst Trans3.20% Short Ratio2.53 Perf Half Y26.11%
Book/sh17.30 P/B4.83 EPS next Y12.11% ROA6.47% Short Interest1.65M Perf Year39.61%
Cash/sh2.84 P/C29.42 EPS next 5Y14.74% ROE24.81% 52W Range57.55 - 87.94 Perf YTD25.10%
Dividend Est.0.60 (0.72%) P/FCF35.64 EPS past 5Y3.48% ROI8.14% 52W High-5.08% Beta0.91
Dividend TTM0.60 (0.72%) Quick Ratio1.37 Sales past 5Y2.74% Gross Margin19.55% 52W Low45.04% ATR (14)1.28
Dividend Ex-DateJul 01, 2024 Current Ratio1.37 EPS Y/Y TTM38.78% Oper. Margin15.35% RSI (14)46.26 Volatility1.17% 1.40%
Employees37761 Debt/Eq1.68 Sales Y/Y TTM5.07% Profit Margin7.57% Recom1.25 Target Price96.00
Option/ShortYes / Yes LT Debt/Eq1.65 EPS Q/Q26.65% Payout17.27% Rel Volume0.67 Prev Close84.49
Sales Surprise3.39% EPS Surprise19.49% Sales Q/Q13.41% EarningsApr 24 AMC Avg Volume653.80K Price83.47
SMA20-1.94% SMA501.72% SMA20016.04% Trades Volume438,841 Change-1.21%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Overweight $95
Mar-14-23Initiated Barclays Equal Weight $57
Sep-24-21Initiated UBS Buy $98
Aug-02-21Upgrade Raymond James Outperform → Strong Buy $95 → $107
Nov-23-20Upgrade Barclays Equal Weight → Overweight $96
Aug-20-20Resumed Barclays Equal Weight $71
Dec-11-19Downgrade Wells Fargo Market Perform → Underperform
Oct-22-19Resumed Stephens Overweight
Sep-17-19Initiated Deutsche Bank Hold $70
Sep-06-19Upgrade BofA/Merrill Neutral → Buy $73
May-24-24 05:00PM
12:45PM
11:31AM
05:22AM
May-23-24 04:15PM
08:30AM Loading…
08:30AM
May-22-24 11:35AM
May-21-24 05:14PM
May-20-24 09:40AM
May-17-24 09:40AM
May-16-24 12:45PM
May-14-24 09:45AM
May-13-24 09:15AM
May-11-24 05:11PM
May-07-24 04:30PM
03:00PM Loading…
03:00PM
03:00PM
11:51AM
May-06-24 05:16PM
May-02-24 09:47AM
09:40AM
May-01-24 04:29PM
11:51AM
Apr-30-24 12:17PM
Apr-29-24 12:08PM
09:13AM
Apr-26-24 09:50AM
09:15AM
03:15AM
12:10AM
09:45AM Loading…
Apr-25-24 09:45AM
Apr-24-24 07:00PM
05:52PM
05:30PM
04:44PM
04:15PM
Apr-23-24 09:15AM
Apr-22-24 01:31PM
Apr-16-24 09:40AM
Apr-10-24 04:30PM
Apr-04-24 01:37PM
Apr-03-24 04:30PM
09:45AM
Apr-02-24 04:30PM
Mar-27-24 04:30PM
09:40AM
Mar-18-24 09:45AM
Mar-15-24 12:46PM
Mar-12-24 11:11AM
Mar-11-24 12:46PM
09:40AM
Mar-10-24 08:38AM
Mar-08-24 11:30AM
Mar-07-24 07:54AM
Mar-05-24 07:45AM
Feb-28-24 09:19AM
Feb-27-24 12:00PM
09:40AM
Feb-23-24 09:40AM
Feb-15-24 04:30PM
Feb-14-24 09:50AM
Feb-09-24 09:13AM
04:31AM
Feb-08-24 01:02PM
Feb-07-24 07:30PM
05:10PM
04:56PM
04:30PM
Feb-05-24 04:00PM
11:23AM
Jan-29-24 09:15AM
Jan-25-24 09:40AM
Jan-10-24 04:30PM
Dec-27-23 11:44AM
Dec-21-23 01:00AM
Dec-19-23 09:50AM
Dec-18-23 09:50AM
Dec-01-23 09:40AM
Nov-29-23 09:50AM
Nov-27-23 08:30AM
Nov-24-23 02:04PM
Nov-16-23 11:49AM
Nov-15-23 12:39PM
11:45AM
Nov-14-23 02:30PM
Nov-13-23 09:40AM
Oct-31-23 09:55AM
Oct-30-23 11:52AM
09:35AM
Oct-28-23 12:50PM
12:27AM
Oct-27-23 12:03PM
Oct-26-23 07:30PM
06:12PM
06:05PM
05:00PM
04:32PM
09:40AM
Oct-25-23 06:50PM
Oct-24-23 07:25AM
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Charbonneau Elissa JoyChief Medical OfficerMay 24 '24Sale85.0210,000850,20018,594May 24 02:36 PM
Darby John PatrickEVP, Gen Counsel & SecretaryMay 06 '24Option Exercise29.0614,543422,62099,316May 07 11:48 AM
Darby John PatrickEVP, Gen Counsel & SecretaryMay 06 '24Sale83.9414,5431,220,73984,773May 07 11:48 AM
CARMICHAEL GREG DDirectorMay 03 '24Buy83.732,000167,46017,050May 07 11:44 AM
Tarr Mark JPresident & CEOApr 30 '24Option Exercise31.9944,9761,438,747599,074May 01 11:47 AM
Tarr Mark JPresident & CEOApr 30 '24Sale83.2744,9763,745,152554,098May 01 11:47 AM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerNov 13 '23Option Exercise26.5516,623441,341127,508Nov 14 11:30 AM
COLTHARP DOUGLAS EEVP & Chief Financial OfficerNov 13 '23Sale63.3911,215710,919116,293Nov 14 11:30 AM
Charbonneau Elissa JoyChief Medical OfficerAug 17 '23Sale69.588,294577,09723,081Aug 18 11:41 AM
Tarr Mark JPresident & CEOAug 16 '23Option Exercise26.5525,330672,512522,735Aug 17 08:44 PM
Tarr Mark JPresident & CEOAug 16 '23Sale71.0625,3301,799,950497,405Aug 17 08:44 PM